back to top

News Detail


Biotech company InflaRx from Jena has entered the NASDAQ

11/20/2017 - The listing at the US-technology stock exchange NASDAQ provide the Thuringian company InflaRx with the sum of 100 mio US$ (about 86 mio Euros) from the capital market. The money will be invested in research, clinical trials and the licensing of antibodies.

InflaRx has specialized in antibodies which are used for combating chronic and life-threatening inflammations and autoimmune diseases. The company was founded in 2007 and was supported by the Thuringian government through private equity company bm-t Beteiligungsmanagement Thüringen mbH - a subsidiary of the Thuringian Development Bank (Thüringer Aufbaubank).



back to top

Search database

Industrial sites

Filter your results

    Companies and technologies

    Filter your results

      Thuringia offers about 400 fully developed and immediately available industrial and commercial sites of all sizes. Our online database gives you an overview of potential properties. In combination with our Company Database, that lists more than 4,000 approved profiles of Thuringian companies, you can also check which companies are located at your chosen site. In addition, this search function is also available for research institutions.